Now Approved | Bimzelx (bimekizumab-bkzx)
discover bimzelx®, now approved to treat multiple indications including psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis.
Total Visits
Avg. Visit Duration
Pages per Visit
Bounce Rate
Registration Date
| Month | Traffic |
|---|---|
| 2025-02 | 115.812 |
| 2025-03 | 99.228 |
| 2025-04 | 109.39 |
| 2025-05 | 106.508 |
| Source | Traffic Share |
|---|---|
| search | 45.36% |
| direct | 36.75% |
| paid referrals | 10.19% |
| referrals | 6.09% |
| social | 1.54% |
| 0.06% |
| Region | Percentage |
|---|---|
| United States | 89.66% |
| Canada | 3.76% |
| United Kingdom | 3.76% |
| IL | 0.93% |
| India | 0.86% |
| Keyword | Traffic | Volume | CPC |
|---|---|---|---|
| bimzelx | 1,404 | 14,040 | $10.75 |
| bimzelx arthritis dosage | 0 | 0 | $0.00 |
| bimzelx hs dosing | 26 | 260 | $0.00 |
| bimzlex | 54 | 540 | $0.00 |
| where can i get a phone number to order my bimzelix | 5 | 50 | $0.00 |